Immunotherapy with HER-2 and VEGF peptide mimics plus metronomic paclitaxel causes superior antineoplastic effects in transplantable and transgenic mouse models of human breast cancer

HER-2 and the vascular endothelial factor receptor (VEGF) represent validated targets for the therapy of multiple tumor types and inhibitors of these receptors have gained increasing importance in the clinic. In this context, novel bioactive agents associated with better therapeutic outcomes and imp...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Foy, Kevin C., Miller, Megan J., Moldovan, Nicanor, Bozanovic, Tatjana, Carson, William E., Kaumaya, Pravin T. P.
Formato: Artigo
Lenguaje:Inglês
Publicado: Landes Bioscience 2012
Materias:
Research Paper
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3494615/
https://ncbi.nlm.nih.gov/pubmed/23170249
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.21057
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares